PURPOSE: A well-established body of literature supports the use of high-dose-rate (HDR)
brachytherapy as definitive treatment for localized prostate cancer. Most of the articles …

Purpose High-dose-rate (HDR) brachytherapy was originally used with external beam
radiation therapy (EBRT) to increase the dose to the prostate without injuring the bladder or …

PURPOSE: There are multiple treatment options for favorable-risk prostate cancer. High-
dose-rate (HDR) brachytherapy as a monotherapy is appealing, but its use is still …

Purpose To review and analyze the published data on high-dose-rate brachytherapy as
monotherapy in the treatment of prostate cancer. Methods A literature search and a …

High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the
cancer with great sparing of surrounding organs at risk. Prostate cancer is thought to be …

PURPOSE: High-dose-rate (HDR) brachytherapy used as the only treatment (monotherapy)
for early prostate cancer is consistent with current concepts in prostate radiobiology, and the …

Purpose To present mature results of high-dose-rate brachytherapy (HDR-BT) as
monotherapy for intermediate-and high-risk prostate cancer. Methods and Materials From …

Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …

Low‐dose rate brachytherapy has become a mainstream treatment option for men
diagnosed with prostate cancer because of excellent long‐term treatment outcomes in low …

Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …